文献速递眼整形与眼眶神经眼科

Epac1 通过 JAK/STAT 信号通路抑制眼眶成纤维细胞活化,改善甲状腺相关眼病样特征

Epac1 Inhibits Orbital Fibroblast Activation to Ameliorate Thyroid-Associated Orbitopathy-Like Features Through the JAK/STAT Signaling Pathway.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

研究探讨 Epac1 在甲状腺相关眼病(TAO)眼眶成纤维细胞活化中的作用及机制。临床 TAO 样本和 TAO 小鼠模型均显示 Epac1 表达降低、波形蛋白升高;Epac1 过表达可减轻 TGFβ1 诱导的促纤维化效应,体内过表达改善 TAO 样症状,机制涉及抑制 STAT3 磷酸化。

要点

  • 临床 TAO 样本与 TAO 小鼠模型均见 Epac1 表达降低、波形蛋白水平升高。
  • Epac1 过表达可抑制 TGFβ1 诱导的眼眶成纤维细胞活力和迁移及纤维化标志物表达。
  • Epac1 过表达在体内改善 TAO 模型小鼠症状,并抑制 STAT3 磷酸化。

核心结论

  • Epac1 通过介导 JAK/STAT 信号通路,是 TAO 纤维化和炎症过程的关键调节因子。

研究设计与样本

  • 收集 TAO 患者与正常健康志愿者的临床眼眶样本,并用表达人 TSHR A 亚基的腺病毒(Ad-TSHR)建立 TAO 小鼠模型。
  • 分离并鉴定临床 TAO 样本来源的眼眶成纤维细胞(TAO OFs)与健康人来源的眼眶成纤维细胞(normal OFs)。
  • 对正常和 TAO 眼眶成纤维细胞转染 Epac1 过表达质粒或 sh-Epac1 质粒,经 TGFβ1 处理,检测细胞表型及 Epac1 和纤维化相关标志物表达。
  • 将过表达 Epac1 的腺相关病毒(AAV-Epac1)注射到 TAO 小鼠眼眶组织,研究 Epac1 对 TGFβ1 刺激的眼眶成纤维细胞的体内抗纤维化作用。
  • 检测 TGFβ1 刺激的 TAO 眼眶成纤维细胞和 TAO 小鼠模型中 STAT3 磷酸化,并使用 JAK/STAT 信号抑制剂 Stattic 探讨 JAK/STAT 信号在 Epac1 功能中的作用。

主要发现

  • 临床 TAO 样本和 TAO 小鼠模型均显示组织病理学显著改变、Epac1 表达降低、波形蛋白水平升高。
  • TGFβ1 刺激显著促进正常和 TAO 眼眶成纤维细胞的细胞活力和迁移,并升高 α-SMA、纤连蛋白、波形蛋白、I 型胶原和 III 型胶原表达水平。
  • Epac1 过表达可显著减弱 TGFβ1 对正常和 TAO 眼眶成纤维细胞的上述促纤维化效应,表现为抑制细胞活力和迁移、降低纤维化标志物表达。
  • Epac1 敲低加重 TGFβ1 诱导的纤维化。
  • 体内 Epac1 过表达改善 TAO 模型小鼠的 TAO 样症状;机制上 Epac1 过表达在体外和体内抑制 STAT3 磷酸化,Stattic 有效减弱 Epac1 敲低对 TGFβ1 处理的 TAO 眼眶成纤维细胞的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Orbital fibroblast (OF) activation plays an important role in thyroid-associated orbitopathy (TAO) development. Epac1, as a cyclic adenosine monophosphate (cAMP) effector, has been recognized as a pivotal mediator of the anti-fibrosis properties of cAMP. This study investigated the role and mechanisms of Epac1 in OF activation. METHODS: Clinical orbital samples were collected from patients with TAO and normal healthy volunteers, and a TAO mouse model was established using adenovirus expressing the human TSHR A subunit (Ad-TSHR), which was evaluated for histopathological features and detected for Epac1 and vimentin expression levels. Clinical TAO samples- (TAO OFs) and healthy people-derived OFs (normal OFs) were isolated and identified using immunofluorescent (IF) staining. Healthy and TAO OFs were transfected with Epac1-overexpressing plasmid (Epac1) for Epac1 overexpression or sh-Epac1 plasmid for Epac1 knockdown, treated with TGFβ1, and then examined for cell phenotypes and the expression level of Epac1 and fibrosis-related markers (α-SMA, fibronectin, and collagens). Furthermore, adeno-associated virus (AAV) overexpressing Epac1 (AAV-Epac1) was injected into TAO mouse orbital tissues to investigate the anti-fibrotic effects of Epac1 on TGFβ1-stimulated OFs in vivo. Moreover, the phosphorylation of STAT3 in the TGFβ1-stimulated TAO OFs and TAO mice model was investigated. The JAK/STAT signaling inhibitor Stattic was used to explore the involvement of the JAK/STAT signaling in the functions of Epac1. RESULTS: Both clinical TAO samples and the TAO mouse model demonstrated significantly changed histopathology, reduced Epac1 expression, and increased vimentin level. TGFβ1 stimulation significantly facilitated cell viability and migration of normal OFs and TAO OFs, and elevated α-SMA, fibronectin, vimentin, collagen I, and collagen III expression levels. However, Epac1 overexpression in OFs could notably attenuate these pro-fibrosis effects of TGFβ1 on both normal and TAO OFs, shown as inhibiting cell viability and migration and decreasing expression of fibrotic markers. Whereas, Epac1 knockdown aggravated TGFβ1-induced fibrosis. In vivo, Epac1 overexpression also improved TAO-like symptoms in TAO model mice. Mechanically, Epac1 overexpression inhibited STAT3 phosphorylation in vitro and in vivo. Stattic effectively attenuated the effects of Epac1 knockdown on TGFβ1-treated TAO OFs. CONCLUSIONS: Epac1 was a critical regulator of fibrotic and inflammatory processes in TAO through mediating the JAK/STAT signaling pathway.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Liu R, Xin X, Ma S, et al. Epac1 Inhibits Orbital Fibroblast Activation to Ameliorate Thyroid-Associated Orbitopathy-Like Features Through the JAK/STAT Signaling Pathway. Invest Ophthalmol Vis Sci. 2025. PMID: 40736178. doi:10.1167/iovs.66.9.68

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。